Table 1.
Serological prevalence of canine vector borne pathogens
Study group |
Study population (N) |
Overall IFA positivity N (%) |
IFA antigens tested |
No. of dogs exposed with > 1 IFA antigen |
SNAP 4DX® |
|||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Bh SA2 | Bh HI | Bvb I | Bvb II | Bvb III | Bk | Rr | Ec | Bc | Lyme | E. canis | Anaplasma spp | Heartworm | ||||
Group I |
47 |
4 (9%) |
0 |
0 |
0 |
0 |
0 |
0 |
1 |
1 |
0 |
2 |
0 |
0 |
0 |
0 |
Group II |
50 |
21 (42%) |
0 |
1 |
0 |
0 |
4 |
0 |
13 |
0 |
0 |
3 |
1 |
8 |
0 |
2 |
Group III | 21 | 4 (19%) | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 1 | 0 | 2 | 0 | 4 | 0 | 6 |
Legend:Bk – B. koehlerae; BhSA2 – Bartonella henselae San Antonio 2; BhHI– Bartonella henselae Houston 1; Bvb – Bartonella vinsonii subsp berkhoffii genotypes I, II, & III; IFA – Immunofluorescent antibody assay; Rr – Rickettsia rickettsii; Ec – Ehrlichia canis; Bc – Babesia canis.